Pinned post

Q&A with David Luan, head of Amazon's AGI research lab, on leaving Adept in a reverse acquihire deal, why he believes progress on AI models has slowed, and more (Alex Heath/The Verge)

Alex Heath / The Verge : Q&A with David Luan, head of Amazon's AGI research lab, on leaving Adept in a reverse acquihire deal, wh...

24 January 2025

Retro Biosciences, the Sam Altman-backed startup that wants to use AI to develop therapies for extending human lifespan by a decade, is raising a $1B Series A (Financial Times)

Financial Times:
Retro Biosciences, the Sam Altman-backed startup that wants to use AI to develop therapies for extending human lifespan by a decade, is raising a $1B Series A  —  The San Francisco-based start-up plans to get its first drug into trials this year  —  Retro Biosciences is raising a $1bn round …

Posted from: this blog via Microsoft Power Automate.

Daily Deals

By on